Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Eisai's squalene synthase inhibitor and prodrug

Aug. 23, 1996

Yamanouchi and PT CarbaPharma describe cathepsin L inhibitor

Aug. 23, 1996

Indian hedgehog molecule's role in cartilage and bone development

Aug. 23, 1996

Osteocalcin study findings reported

Aug. 23, 1996

Aredia earns U.S. approval for new indication

Aug. 23, 1996

Conceptus reports clinical advances with S/TOP system

Aug. 16, 1996

Zonagen initiates pivotal trials of Vasomax

Aug. 16, 1996

Andropatch marketed in U.K.

Aug. 16, 1996

BASF to manufacture Ares-Serono's hGH

Aug. 16, 1996

Antidiabetic potential of CDP-571 assessed, rejected in human trials

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...